Buscar
Mostrando ítems 1-5 de 5
Preprint
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
| Fecha del documento:
2022 | Derechos de autor:
open access
Preprint
Non-permissive SARS-CoV-2 infection in human neurospheres (preprint)
| Fecha del documento:
2021 | Derechos de autor:
open access
Preprint
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
| Fecha del documento:
2020 | Derechos de autor:
open access
Preprint
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
| Fecha del documento:
2020 | Derechos de autor:
open access
Preprint
Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics
| Fecha del documento:
2021 | Derechos de autor:
open access